Understanding mTNBC - Metastatic Triple-Negative Breast Cancer


 

Key Takeaways:

  • TNBC accounts for approximately 10% to 15% of all existing breast cancers.
  • The majority of cases of Triple-Negative Breast Cancer are diagnosed in women aged 51 to 60 years.
  • Triple-Negative Breast Cancer more commonly affects African American and Hispanic women.
  • Breast cancer linked with a BRCA-1/BRCA-2 mutation is often, but not always, triple negative.

mTNBC and Other Types of Breast Cancer:

Different types of breast cancer are grouped by whether or not the cancerous cells have certain protein-named receptors. Cancerous cells typically may have a couple of types of hormones (either estrogen or progesterone) or another receptor named HER2. 

If cancerous cells have (or are +Ve for)these receptors, they can be treated with therapies that are mainly designed to target those receptors or that result in making fewer hormones.

But metastatic triple-negative breast cancer cells are negative for estrogen receptors (ER), progesterone receptors (PR), and HER2, which typically means they tested negative for ER, PR, and HER2, hence the name triple-negative breast cancer (TNBC). 

Without these three receptors, treatment for metastatic triple-negative breast cancer is more limited than other sorts of breast cancer and may need a different outlook.

Treatment for metastatic Triple-Negative Breast Cancer (mTNBC):

There is a medicine in the town named Trodelvy, which is the only Metastatic Triple-Negative Breast cancer drug of its kind. Unlike some other medicines, Trodelvy 180 mg does not need unhealthy cells to have ER, PR, or HER2 to work, which is why the medicinal product is a potential option for those with metastatic triple-negative breast cancer.

Rather, the medicine Trodelvy is designed to seek out a different protein that may exist on breast cancer cells, including those found in metastatic triple-negative breast cancer.

Buy Trodelvy from The Indian Pharma:

Trodelvy injection price in India is low and can vary. If you are looking to procure/buy Trodelvy injections hassle-free at a reasonable price from India, then we can be your one-stop solution. Kindly get in touch with us through TOLL-FREE Number: 1800-889-1064. We are a WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Exporter/ Importer and Supplier of Trodelvy sacituzumab govitecan-hziy 180 mg/200 mg from India.

Reference:

https://www.ema.europa.eu/en/medicines/human/EPAR/trodelvy

Comments

Post a Comment

Popular posts from this blog

Buy Trodelvy sacituzumab govitecan-hziy in India

  Trodelvy Overview: Trodelvy is widely prescribed by Oncologists for the treatment of patients with HR+/HER2- Metastatic Breast Cancer, Metastatic Triple-Negative Breast Cancer (mTNBC), and Metastatic Urothelial Cancer (mUC). It is considered a promising treatment option for those who are not ideal candidates for some conventional therapies. Developed by Immunomedics, Trodelvy 180 mg and Trodelvy 200 mg are two available commercial strengths. Worldwide, Trodelvy is promoted and facilitated by Gilead Sciences. Trodelvy is first approved on 22 April 2020. It is given by intravenous (IV) infusion by a health specialist. The medication received its (European Medicines Agency) EMA approval in October 2021. Trodelvy 180 mg and 200 mg injections are yet to be approved in India. The cost of Trodelvy in India usually depends on international factors. Buy Trodelvy from a Reliable Source: Many suppliers who are not authorized to handle or supply life-saving medicines such as Trodelvy found ...
Read more

Lenvatinib Medication Guide

Lenvatinib is recommended for treating patients with locally recurrent, progressive, metastatic, radioactive iodine-refractory differentiated thyroid cancer (RAI-refractory DTC), together with everolimus for advanced renal cell carcinoma and for hepatocellular carcinoma.  Here are a few important points for patients before taking Lenvatinib:- Female patients who are able to become pregnant must use an effective method of birth control while on the treatment with lenvatinib and for at least 2 weeks after its last dose. Discuss with your doctor about the birth control methods you can use during this time. Lenvatinib is taken at the same time each and every day. If a patient misses any dose, and it cannot be consumed within 12 hours, then that dose must be skipped and the next dose should be consumed at the usual time of administration. The recommended dose is lenvatinib 24 mg (two lenvatinib 10 mg capsules and one lenvatinib 4 mg capsule) orally, taken once in a day, either with or...
Read more

Difference Between Multiple Myeloma And Leukemia

Image
What is multiple myeloma:  This is also known as plasma cell myeloma or Kahler's disease. It is a cancer in plasma cells that typically produce antibodies. When there is only one tumor present it is called as plasmacytoma and when more than one then called as multiple myeloma. The main cause of myeloma is unknown but the major risk factors are obesity,  inheritance chemicals, radiation, etc. With the effect of cancer, there is an abnormality in plasma cells that produces abnormal antibodies that can cause kidney problems. At the initial stage, there is no sign and symptoms but with the advancement of time bone pain, bleeding, anemia and frequent infections are the common symptoms. Multiple myeloma is diagnosed with the help of blood or urine tests or bone marrow biopsy. And the medication of multiple myeloma includes: Chemotherapy- There are several drugs that are used in the treatment of multiple myeloma such as doxorubicin, etoposide, cisplatin, cyclophosphami...
Read more